Trials / Completed
CompletedNCT01970306
Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
A Prospective Phase II Trial to Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if implanting MatriStem will lower the risk of one of the more common complications after stomach or esophagus surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MatriStem PSM | All esophageal anastomoses will be reinforced circumferentially with ACell MatriStem PSM. |
Timeline
- Start date
- 2013-10-18
- Primary completion
- 2023-02-24
- Completion
- 2023-02-24
- First posted
- 2013-10-28
- Last updated
- 2023-11-03
- Results posted
- 2023-11-03
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01970306. Inclusion in this directory is not an endorsement.